![]() |
Volumn 346, Issue , 2013, Pages
|
Roche offers researchers access to all Tamiflu trials.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
OSELTAMIVIR;
ACCESS TO INFORMATION;
CLINICAL TRIAL (TOPIC);
CONFIDENTIALITY;
DRUG INDUSTRY;
HUMAN;
INFLUENZA;
NOTE;
PERSONNEL;
PHASE 3 CLINICAL TRIAL (TOPIC);
SWITZERLAND;
ACCESS TO INFORMATION;
ANTIVIRAL AGENTS;
CLINICAL TRIALS AS TOPIC;
CLINICAL TRIALS, PHASE III AS TOPIC;
CONFIDENTIALITY;
DRUG INDUSTRY;
HUMANS;
INFLUENZA, HUMAN;
OSELTAMIVIR;
RESEARCH PERSONNEL;
SWITZERLAND;
|
EID: 84878215148
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.f2157 Document Type: Note |
Times cited : (4)
|
References (0)
|